Pelvic inflammatory disease (PID): Nursing process (ADPIE)

Pelvic inflammatory disease (PID): Nursing process (ADPIE)

gap test med surg

gap test med surg

Aortic aneurysm: Nursing process (ADPIE)
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Hypertension: Nursing process (ADPIE)
Left-sided heart failure: Nursing process (ADPIE)
Myocardial infarction (MI): Nursing process (ADPIE)
Pericardial effusion and cardiac tamponade: Nursing process (ADPIE)
Rheumatic heart disease: Nursing process (ADPIE)
Antihyperlipidemics - Statins: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Diabetes insipidus: Nursing process (ADPIE)
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Hyperosmolar hyperglycemic state (HHS): Nursing process (ADPIE)
Hyperthyroidism: Nursing process (ADPIE)
Hypothyroidism: Nursing process (ADPIE)
Syndrome of inappropriate antidiuretic hormone (SIADH): Nursing process (ADPIE)
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Insulin: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Epistaxis: Nursing process (ADPIE)
Eye injury: Nursing process (ADPIE)
Glaucoma: Nursing process (ADPIE)
Tonsillitis: Nursing process (ADPIE)
Antiglaucoma medications: Nursing pharmacology
Eye anesthetics: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Laxatives: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Antiemetics: Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Acute kidney injury (AKI): Nursing process (ADPIE)
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Urinary incontinence - Stress: Nursing process (ADPIE)
Urinary tract infections (UTIs): Nursing process (ADPIE)
Hemophilia: Nursing process (ADPIE)
Leukemia: Nursing process (ADPIE)
Sickle cell disease: Nursing process (ADPIE)
Anticoagulants - Heparin: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Hemostatics: Nursing pharmacology
Iron preparations: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Blood products: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Vaccines: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Atopic dermatitis: Nursing process (ADPIE)
Frostbite: Nursing process (ADPIE)
Methicillin-resistant Staphylococcus aureus (MRSA): Nursing process (ADPIE)
Pressure injury: Nursing process (ADPIE)
Debridement agents: Nursing pharmacology
Keratolytics: Nursing pharmacology
Antibiotics - Topical: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Acute compartment syndrome: Nursing process (ADPIE)
Fractures: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Analgesics: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Skeletal muscle relaxants: Nursing pharmacology
Medications for migraines: Nursing pharmacology
Meningitis: Nursing process (ADPIE)
Parkinson disease: Nursing process (ADPIE)
Seizure disorder: Nursing process (ADPIE)
Stroke: Nursing process (ADPIE)
Trigeminal neuralgia: Nursing process (ADPIE)
Breast cancer: Nursing process (ADPIE)
Tumor lysis syndrome (TLS): Nursing Process (ADPIE)
Plant extracts for chemotherapy: Nursing pharmacology
Antitumor antibiotics: Nursing pharmacology
Alkylating agents: Nursing pharmacology
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Candidiasis: Nursing process (ADPIE)
Gonorrhea and chlamydia: Nursing process (ADPIE)
Pelvic inflammatory disease (PID): Nursing process (ADPIE)
Asthma: Nursing process (ADPIE)
Bacterial pneumonia: Nursing process (ADPIE)
Carbon monoxide poisoning: Nursing process (ADPIE)
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Epiglottitis: Nursing process (ADPIE)
Foreign body aspiration and upper airway obstruction: Nursing process (ADPIE)
Laryngotracheobronchitis (LTB) and croup: Nursing process (ADPIE)
Smoke inhalation injury: Nursing process (ADPIE)
Venous thromboembolism (VTE): Nursing process (ADPIE)
Antihistamines: Nursing pharmacology
Bronchodilators: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Mast cell stabilizers - Inhaled: Nursing pharmacology
Leukotriene modifiers: Nursing pharmacology
Medications to control airway secretions: Nursing pharmacology
Oxygen therapy: Nursing pharmacology

Notes

PELVIC INFLAMMATORY DISEASE (PID)

KEY POINTS
NOTES
PATIENT REPORT
  • 25-year-old 
  • Gynecology office 
  • Reports lower abdominal pain, fever, and yellow, foul-smelling vaginal discharge
  • Diagnosis: PID

PATHOPHYSIOLOGY
  • Infection of the upper female reproductive tract 
  • Affects uterus, fallopian tubes, and ovaries 
  • Commonly caused by STIs 
    • Chlamydia trachomatis 
    • Neisseria gonorrhoeae 
  • Can also result from 
    • Bacterial vaginosis  
    • Introduction of bacteria during surgery, abortion, or childbirth 
  • May be polymicrobial
  • Risk factors 
    • Modifiable 
      • Unprotected sex 
      • New or multiple sexual partners 
    • Non-modifiable 
      • Age < 35 
      • History of PID, STIs, or bacterial vaginosis 
  • Symptoms 
    • May be asymptomatic or mild 
    • If symptomatic 
      • Fever 
      • Pelvic pain 
      • Ovarian and fallopian tube tenderness 
      • Dyspareunia  
      • Mucopurulent vaginal discharge 
      • Irregular uterine bleeding 
  • Complications 
  • Fallopian tube adhesions and strictures 
  • Increased risk of ectopic pregnancy 
  • Infertility 
  • Tubo-ovarian abscess (can rupture and cause sepsis) 
  • Fitz-Hugh-Curtis syndrome 

DIAGNOSIS AND TREATMENT
  • Diagnosis
    • History
    • Physical assessment
    • Lab tests
    • Diagnostic imaging
  • Treatment
    • Antibiotics
    • Analgesics
    • Surgery

ASSESSMENT
  • Patient appears uncomfortable 
  • Guarding lower abdomen 
  • Patient reports
    • Several past biological male sexual partners 
    • No biological female sexual partners 
    • Inconsistent condom use 
    • Last intercourse 2 days ago, reported as painful 
    • Last menstrual cycle ended 5 days ago 
  • Vital signs 
    • Temperature: 101.2°F (38.4°C) 
    • Heart rate: 100/min
    • Respiratory rate: 18/min
    • Blood pressure: 126/82 mmHg 
    • SpO2: 98% room air 
    • Pain: 7/10
      • Lower abdomen, achy and cramping, worsens with movement 
  • Physical assessment 
    • Skin: warm, no rashes or lesions, normal turgor 
    • Oral mucosa: moist and pink 
    • Capillary refill: < 3 seconds 
    • Peripheral pulses: 3+ and equal bilaterally 
    • Bowel sounds: active  
  • Laboratory findings 
    • Leukocytes: 14,000/mm³ (14 x 109/L)
    • Erythrocyte sedimentation rate (ESR): 40 mm/h 
    • Beta hCG: 1.0 IU/L 
    • Urinalysis: positive for WBCs, no organisms 
    • Pending tests: gonorrhea, chlamydia, HIV

NURSING DIAGNOSES
  • Risk for infection related to potential for abscess to rupture and sepsis
  • Acute pain related to pelvic inflammation
  • Ineffective health maintenance related to deficient knowledge regarding prevention and treatment of STIs

PLANNING
  • By end of shift, patient will
    • Exhibit no signs of a ruptured abscess or sepsis
    • Achieve pain control at stated tolerable level of 3/10
    • Demonstrate understanding of PID and ways to prevent STIs

IMPLEMENTATION
  • Reviewed HCP orders 
  • Collaborated with patient care technician (PCT) 
    • Delegated collection of vital signs and intake/output
  • Ensured semi-Fowler position to promote pelvic drainage 
  • Administered IV antibiotics, antipyretic, & analgesic
  • Applied heating pad to lower abdomen 
  • Taught about PID
  • Discussed STI risk reduction 
  • Informed that recent partners must be assessed and treated 
  • Advised to abstain from sexual activity until 
    • Antibiotic regimen is completed 
    • Follow-up STI test results are received 
  • Explained potential complications of PID 
  • Monitored for signs of sepsis 
  • Monitored for increasing pain 
  • Noted that changes require urgent provider notification

EVALUATION
  • Vital signs 
    • Temperature: 99.4°F (37.4°C) 
    • Heart rate: 80/min 
    • Respiratory rate: 16/min 
    • Blood pressure: 118/78 mmHg 
    • SpO2: 99% room air 
    • Pain: 3/10 
  • Patient verbalized understanding of education provided 
  • No signs of ruptured abscess or sepsis 

Transcript

Watch video only

Margarita Salvador is a 25-year-old female client who presents to her gynecologist’s office with a report of lower abdominal pain, a fever of 101°F or 38.3°C, chills and thick, yellow foul smelling vaginal discharge.

She states her symptoms began three days ago. A pelvic examination is positive for cervical motion tenderness and right-sided adnexal tenderness. A transvaginal ultrasound visualizes a 4 cm right-sided tubo-ovarian abscess.

A vaginal swab was sent for laboratory analysis to check for chlamydia and gonorrhea. Ms. Salvador is diagnosed with pelvic inflammatory disease, or PID, and will be admitted to the medical surgical unit for treatment.

Pelvic inflammatory disease, or PID for short, is an infection of the upper female reproductive system, which includes the uterus, fallopian tubes, and ovaries.

Most often, PID develops from a bacterial infection that begins in the vagina or cervix, such as sexually transmitted infections, or STIs, like chlamydia, caused by Chlamydia trachomatis, and gonorrhea, caused by Neisseria gonorrhoeae.

Another cause of PID can be bacterial vaginosis, which refers to the infection of the vagina due to overgrowth of bacteria like Gardnerella vaginalis, which are normally present in low numbers in the vaginal flora.

Occasionally, PID can be caused by other forms of bacteria introduced in the reproductive tract during surgery, abortion, or even childbirth. Now, PID is typically caused by only one type of bacteria, but in some clients, the infection can become polymicrobial, meaning the original infection makes it easier for other bacteria to settle into the reproductive tract.

Risk factors associated with pelvic inflammatory disease can be subdivided into two main groups. Modifiable risk factors include having unprotected sexual contact, as well as new or multiple sexual partners.

On the other hand, non-modifiable risk factors include being under the age of 35, since they’re more likely to have new or multiple sexual partners, as well as having a history of prior pelvic inflammatory disease, STIs, or bacterial vaginosis.

Some clients with PID will have no or mild symptoms. On the other hand, symptomatic clients may present with fever, pelvic pain, and tenderness around the ovaries and fallopian tubes, as well as dyspareunia, which is pain during sexual intercourse.

Additionally, some may complain of mucopurulent vaginal discharge or irregular uterine bleeding. Pelvic inflammatory disease can cause some serious complications, such as adhesions and strictures of the fallopian tubes, subsequently increasing the risk of ectopic pregnancy and infertility.

In addition, if pus builds up in a tube and ovary, it can turn into a tubo-ovarian abscess, which can rupture and spread into the bloodstream, leading to sepsis.

Finally, if the inflammation affects the peritoneum and Glisson’s capsule surrounding the liver, it can result in strings of scar tissue that attach the liver to the peritoneum.

These “violin string” adhesions are also known as Fitz-Hugh-Curtis syndrome, which is also called perihepatitis. Diagnosis of PID is usually based on history and clinical findings, such as pelvic pain and cervical motion tenderness, which refers to the pain and discomfort that occurs during mobilization of the cervix.

In some clients, the cervix can also be inflamed, erythematous, and bleed easily when touched. In addition, it’s important to check blood levels of beta human chorionic gonadotropin, or beta hCG for short, and perform an ultrasound to rule out pregnancy.

Ultrasound can also help visualize complications like a tubo-ovarian abscess. Next, a swab sample from the inside of the vagina or cervix can be tested for chlamydia and gonorrhea, using the nucleic acid amplification test or NAAP for short.

Finally, urinalysis can be performed to rule out urinary tract infections that might present with similar clinical findings. Clients with pelvic inflammatory disease are typically treated with a mix of antibiotics, including ceftriaxone or cefotetan, doxycycline, and metronidazole.

Additionally, analgesics like acetaminophen or NSAIDs can be used to manage pain. Some clients might require surgery to remove adhesions or treat complications.

Now, let’s get back to Ms. Salvador and begin her assessment. As you enter her room you note Ms. Salvador appears uncomfortable and is guarding her lower abdomen.

While reviewing her history, she tells you she has had several male sexual partners in the past and no female sexual partners. She does not routinely use protection and last had intercourse two days ago, which she recalls as being painful.